SCHEMBL17028066

SCHEMBL17028066

Cc1nc(C(F)(F)F)cnc1N[C@H]1CCCC1NC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 20/20 0.65
HCRTR2 O43614 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17007140 1.00 HCRTR1 (0.65) HCRTR1HCRTR2
SCHEMBL17007266 0.87 HCRTR1 (0.65) HCRTR1HCRTR2
SCHEMBL17007385 0.86 HCRTR1 (0.51) HCRTR1HCRTR2
SCHEMBL17007313 0.86 HCRTR1 (0.59) HCRTR1HCRTR2
SCHEMBL17007246 0.85 HCRTR1 (0.64) HCRTR1HCRTR2
SCHEMBL17007221 0.83 HCRTR1 (0.48) HCRTR1HCRTR2
SCHEMBL17166533 0.83 HCRTR1 (0.54) HCRTR1HCRTR2
SCHEMBL22877019 0.83 HCRTR1 (0.54) HCRTR1HCRTR2
SCHEMBL17017337 0.82 HCRTR1 (0.53) HCRTR1HCRTR2
SCHEMBL17028043 0.80 HCRTR1 (1.00) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3107898-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS Takeda Pharmaceutical Company Limited (JP) 2016-12-28 EP disclosed
WO-2015124932-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS TAKEDA CAMBRIDGE LIMITED (GB) 2015-08-27 WO disclosed